Literature DB >> 19370795

Furazolidone therapy for Helicobacter pylori: is it effective and safe?

Vincenzo De Francesco, Enzo Ierardi, Cesare Hassan, Angelo Zullo.   

Abstract

Some aspects related with the use of furazolidone as a rescue therapy for Helicobacter pylori (H pylori) infection should be remarked, especially regarding its potential oncologic risk. The inclusion of furazolidone in a treatment regimen for H pylori infection is, at least, controversial, and it does not appear to be safe.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19370795      PMCID： PMC2670425          DOI： 10.3748/wjg.15.1914

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  6 in total

1.  A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

Authors:  L Gatta; A Zullo; F Perna; C Ricci; V De Francesco; A Tampieri; V Bernabucci; M Cavina; C Hassan; E Ierardi; S Morini; D Vaira
Journal:  Aliment Pharmacol Ther       Date:  2005-07-01       Impact factor: 8.171

2.  Attenuating effect of the monoamine oxidase inhibitor furazolidone on the anti-carcinogenetic effect of cysteamine on gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.

Authors:  M Tatsuta; H Iishi; M Baba; H Taniguchi
Journal:  Int J Cancer       Date:  1991-06-19       Impact factor: 7.396

3.  Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease.

Authors:  Guilherme-Eduardo-Goncalves Felga; Fernando-Marcuz Silva; Ricardo-Correa Barbuti; Tomas Navarro-Rodriguez; Schlioma Zaterka; Jaime-Natan Eisig
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

4.  Potential role of cysteine and methionine in the protection against hormonal imbalance and mutagenicity induced by furazolidone in female rats.

Authors:  Hanaa H Ahmed; Sekena H Abd El-Aziem; Mosaad A Abdel-Wahhab
Journal:  Toxicology       Date:  2007-09-22       Impact factor: 4.221

Review 5.  The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis.

Authors:  Angelo Zullo; Vincenzo De Francesco; Cesare Hassan; Sergio Morini; Dino Vaira
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

6.  A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication.

Authors:  A Zullo; C Hassan; V De Francesco; R Lorenzetti; M Marignani; S Angeletti; E Ierardi; S Morini
Journal:  Dig Liver Dis       Date:  2003-04       Impact factor: 4.088
  6 in total
  7 in total

1.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 2.  Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.

Authors:  Simona Di Caro; Lucia Fini; Yayha Daoud; Fabio Grizzi; Antonio Gasbarrini; Antonino De Lorenzo; Laura Di Renzo; Sara McCartney; Stuart Bloom
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

3.  Helicobacter pylori infection in India from a western perspective.

Authors:  Selvi Thirumurthi; David Y Graham
Journal:  Indian J Med Res       Date:  2012-10       Impact factor: 2.375

Review 4.  Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis.

Authors:  Angelo Zullo; Enzo Ierardi; Cesare Hassan; Vincenzo De Francesco
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

5.  Risk factors of furazolidone-associated fever.

Authors:  Jiali Zhang; Chunling Rong; Chenyang Yan; Jie Chen; Wenjun Yang; Lingyan Yu; Haibin Dai
Journal:  PLoS One       Date:  2022-04-08       Impact factor: 3.240

6.  Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology.

Authors:  Shivaram Prasad Singh; Vineet Ahuja; Uday C Ghoshal; Govind Makharia; Usha Dutta; Showkat Ali Zargar; Jayanthi Venkataraman; Amit Kumar Dutta; Asish K Mukhopadhyay; Ayaskanta Singh; Babu Ram Thapa; Kim Vaiphei; Malathi Sathiyasekaran; Manoj K Sahu; Niranjan Rout; Philip Abraham; Prakash Chandra Dalai; Pravin Rathi; Saroj K Sinha; Shobna Bhatia; Susama Patra; Ujjala Ghoshal; Ujjal Poddar; Venigalla Pratap Mouli; Vikram Kate
Journal:  Indian J Gastroenterol       Date:  2021-07-05

7.  Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication.

Authors:  Ya-Wen Zhang; Wei-Ling Hu; Yuan Cai; Wen-Fang Zheng; Qin Du; John J Kim; John Y Kao; Ning Dai; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2018-10-28       Impact factor: 5.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.